endo h Search Results


99
New England Biolabs endo β n acetylglucosaminidase h
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endo β N Acetylglucosaminidase H, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/Endo+H/pmc12939213-58-0-7
Average 99 stars, based on 1 article reviews
endo β n acetylglucosaminidase h - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
New England Biolabs endo h enzyme
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endo H Enzyme, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/Endo+H/pm35577790-437-6-9
Average 99 stars, based on 1 article reviews
endo h enzyme - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
Promega endo h
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endo H, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/endo+h/pmc03875743-607-37-39
Average 90 stars, based on 1 article reviews
endo h - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Seikagaku corporation endo-β-nacetylglucosaminidase h (endo h)
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endo β Nacetylglucosaminidase H (Endo H), supplied by Seikagaku corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/endo++++n+acetylglucosaminidase+h++endo+h+/pm19129245-220-0-8
Average 90 stars, based on 1 article reviews
endo-β-nacetylglucosaminidase h (endo h) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson endoglycosidase h (endo h
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endoglycosidase H (Endo H, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/endoglycosidase+h++endo+h/10__2147_slash_cmar__s235791-30-6-13
Average 90 stars, based on 1 article reviews
endoglycosidase h (endo h - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
DuPont de Nemours endo-beta-n-acetylglucosaminidase h (endo h)
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endo Beta N Acetylglucosaminidase H (Endo H), supplied by DuPont de Nemours, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/endo+beta+n+acetylglucosaminidase+h+endo+h/us06967029-391-15-20
Average 90 stars, based on 1 article reviews
endo-beta-n-acetylglucosaminidase h (endo h) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Miles Laboratories endo h
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endo H, supplied by Miles Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/endo+h/pm06319581-51-7-8
Average 90 stars, based on 1 article reviews
endo h - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Seikagaku corporation endo-/3-galactosidase from pseudomonas sp
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endo /3 Galactosidase From Pseudomonas Sp, supplied by Seikagaku corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/endo++3+n+acethylglucosaminidase+h++endo+h+/10__1042_slash_bj2590021-35-0-7
Average 90 stars, based on 1 article reviews
endo-/3-galactosidase from pseudomonas sp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Oxford Glycosystems endoh
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endoh, supplied by Oxford Glycosystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/endo+h/10__1074_slash_jbc__m002373200-72-35-38
Average 90 stars, based on 1 article reviews
endoh - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Promega pngase f, endo h
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Pngase F, Endo H, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/pngase+f++endo+h/pmc10404741-233-14-16
Average 90 stars, based on 1 article reviews
pngase f, endo h - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Promega streptomyces plicatus endoglycosidase h (endo h
A ) i) The MPO N -glycans are positioned distal to the catalytic site. Zoom: Oxidation-prone Met251, Met253 and Trp255 (yellow) in the heme-containing (orange) catalytic site. Mapped on monoprotomeric MPO (PDBID, 1D2V), see for key. ii) Hyper-oxidation of Met251, Met253 and Trp255 indicates extensive auto-oxidation. iii) Se/Pl-MPO from Donor a–b neutrophils displayed a higher chlorination and oxidation activity than MPO from other granules ( Supplementary Table S11 ). Adjusted for MPO levels, n = 3, technical replicates. iv) Relative Tyr chlorination level of proteins from granules fractionated with high resolution of neutrophils from Donor c–f ( Supplementary Table S12 ). Adjusted for total protein and MPO levels, n = 4, biological replicates. B ) i) <t>Endo</t> <t>H-treatment</t> of nMPO produced an Asn355- and Asn391-GlcNAc glycophenotype (mimicking the enriched GlcNAcβAsn signatures of Se/Pl-MPO, see ) as validated using LC-MS/MS . Main glycoforms are depicted for each site. ii) The Endo H-treated nMPO exhibited a higher enzyme activity than native nMPO based on technical triplicate measurements of HOCl production (activity assay 1) and the oxidation rate (activity assays 2–3) ( Supplementary Table S5A-C ). C ) Endo H-treated and untreated nMPO displayed indistinguishable secondary structure profiles based on i) CD profiling ( Supplementary Table S13A-B ) and ii) MD-based predictions. D ) Relative to native nMPO (WT), Endo H-treated MPO (P1) showed i) higher thermal stability as determined by CD 208 nm (arrows indicate initial melting temperatures) and ii) greater global polypeptide accessibility based on MD data ( Supplementary Figure S8-S9 ). Key: a–e and i–ii indicate positions of the MPO glycosylation sites and key catalytic residues, respectively. For panel Bii, Ci, and Di: ^Data from Endo H only controls were subtracted from Endo H-treated nMPO data to enable comparison to untreated nMPO. For all panels: Data plotted as mean ± SD, ns, not significant ( p ≥ 0.05), * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001, ***** p < 0.00005.
Streptomyces Plicatus Endoglycosidase H (Endo H, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/streptomyces+plicatus+endoglycosidase+h+endo+h/bio_rxiv__2020__07__24__219956-82-7-13
Average 90 stars, based on 1 article reviews
streptomyces plicatus endoglycosidase h (endo h - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Seikagaku corporation endoglycosidases h endo h; s. griseus
A ) i) The MPO N -glycans are positioned distal to the catalytic site. Zoom: Oxidation-prone Met251, Met253 and Trp255 (yellow) in the heme-containing (orange) catalytic site. Mapped on monoprotomeric MPO (PDBID, 1D2V), see for key. ii) Hyper-oxidation of Met251, Met253 and Trp255 indicates extensive auto-oxidation. iii) Se/Pl-MPO from Donor a–b neutrophils displayed a higher chlorination and oxidation activity than MPO from other granules ( Supplementary Table S11 ). Adjusted for MPO levels, n = 3, technical replicates. iv) Relative Tyr chlorination level of proteins from granules fractionated with high resolution of neutrophils from Donor c–f ( Supplementary Table S12 ). Adjusted for total protein and MPO levels, n = 4, biological replicates. B ) i) <t>Endo</t> <t>H-treatment</t> of nMPO produced an Asn355- and Asn391-GlcNAc glycophenotype (mimicking the enriched GlcNAcβAsn signatures of Se/Pl-MPO, see ) as validated using LC-MS/MS . Main glycoforms are depicted for each site. ii) The Endo H-treated nMPO exhibited a higher enzyme activity than native nMPO based on technical triplicate measurements of HOCl production (activity assay 1) and the oxidation rate (activity assays 2–3) ( Supplementary Table S5A-C ). C ) Endo H-treated and untreated nMPO displayed indistinguishable secondary structure profiles based on i) CD profiling ( Supplementary Table S13A-B ) and ii) MD-based predictions. D ) Relative to native nMPO (WT), Endo H-treated MPO (P1) showed i) higher thermal stability as determined by CD 208 nm (arrows indicate initial melting temperatures) and ii) greater global polypeptide accessibility based on MD data ( Supplementary Figure S8-S9 ). Key: a–e and i–ii indicate positions of the MPO glycosylation sites and key catalytic residues, respectively. For panel Bii, Ci, and Di: ^Data from Endo H only controls were subtracted from Endo H-treated nMPO data to enable comparison to untreated nMPO. For all panels: Data plotted as mean ± SD, ns, not significant ( p ≥ 0.05), * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001, ***** p < 0.00005.
Endoglycosidases H Endo H; S. Griseus, supplied by Seikagaku corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endo+h/endoglycosidases+h+endo+h++s++griseus/pm09572291-36-0-14
Average 90 stars, based on 1 article reviews
endoglycosidases h endo h; s. griseus - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.

Journal: Foods

Article Title: Boosting Recombinant Bovine Chymosin in Komagataella phaffii via Fusion Protein and Constitutive Promoter Expression

doi: 10.3390/foods15040731

Figure Lengend Snippet: Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.

Article Snippet: Endo-β-N-acetylglucosaminidase H (Endo H) was obtained from New England Biolabs (Ipswich, MA, USA).

Techniques: Purification, Recombinant, SDS Page, Staining, Molecular Weight, Activation Assay, Concentration Assay, Membrane

A ) i) The MPO N -glycans are positioned distal to the catalytic site. Zoom: Oxidation-prone Met251, Met253 and Trp255 (yellow) in the heme-containing (orange) catalytic site. Mapped on monoprotomeric MPO (PDBID, 1D2V), see for key. ii) Hyper-oxidation of Met251, Met253 and Trp255 indicates extensive auto-oxidation. iii) Se/Pl-MPO from Donor a–b neutrophils displayed a higher chlorination and oxidation activity than MPO from other granules ( Supplementary Table S11 ). Adjusted for MPO levels, n = 3, technical replicates. iv) Relative Tyr chlorination level of proteins from granules fractionated with high resolution of neutrophils from Donor c–f ( Supplementary Table S12 ). Adjusted for total protein and MPO levels, n = 4, biological replicates. B ) i) Endo H-treatment of nMPO produced an Asn355- and Asn391-GlcNAc glycophenotype (mimicking the enriched GlcNAcβAsn signatures of Se/Pl-MPO, see ) as validated using LC-MS/MS . Main glycoforms are depicted for each site. ii) The Endo H-treated nMPO exhibited a higher enzyme activity than native nMPO based on technical triplicate measurements of HOCl production (activity assay 1) and the oxidation rate (activity assays 2–3) ( Supplementary Table S5A-C ). C ) Endo H-treated and untreated nMPO displayed indistinguishable secondary structure profiles based on i) CD profiling ( Supplementary Table S13A-B ) and ii) MD-based predictions. D ) Relative to native nMPO (WT), Endo H-treated MPO (P1) showed i) higher thermal stability as determined by CD 208 nm (arrows indicate initial melting temperatures) and ii) greater global polypeptide accessibility based on MD data ( Supplementary Figure S8-S9 ). Key: a–e and i–ii indicate positions of the MPO glycosylation sites and key catalytic residues, respectively. For panel Bii, Ci, and Di: ^Data from Endo H only controls were subtracted from Endo H-treated nMPO data to enable comparison to untreated nMPO. For all panels: Data plotted as mean ± SD, ns, not significant ( p ≥ 0.05), * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001, ***** p < 0.00005.

Journal: bioRxiv

Article Title: Hyper-Truncated Glycans Augment the Activity of Neutrophil Granule Myeloperoxidase

doi: 10.1101/2020.07.24.219956

Figure Lengend Snippet: A ) i) The MPO N -glycans are positioned distal to the catalytic site. Zoom: Oxidation-prone Met251, Met253 and Trp255 (yellow) in the heme-containing (orange) catalytic site. Mapped on monoprotomeric MPO (PDBID, 1D2V), see for key. ii) Hyper-oxidation of Met251, Met253 and Trp255 indicates extensive auto-oxidation. iii) Se/Pl-MPO from Donor a–b neutrophils displayed a higher chlorination and oxidation activity than MPO from other granules ( Supplementary Table S11 ). Adjusted for MPO levels, n = 3, technical replicates. iv) Relative Tyr chlorination level of proteins from granules fractionated with high resolution of neutrophils from Donor c–f ( Supplementary Table S12 ). Adjusted for total protein and MPO levels, n = 4, biological replicates. B ) i) Endo H-treatment of nMPO produced an Asn355- and Asn391-GlcNAc glycophenotype (mimicking the enriched GlcNAcβAsn signatures of Se/Pl-MPO, see ) as validated using LC-MS/MS . Main glycoforms are depicted for each site. ii) The Endo H-treated nMPO exhibited a higher enzyme activity than native nMPO based on technical triplicate measurements of HOCl production (activity assay 1) and the oxidation rate (activity assays 2–3) ( Supplementary Table S5A-C ). C ) Endo H-treated and untreated nMPO displayed indistinguishable secondary structure profiles based on i) CD profiling ( Supplementary Table S13A-B ) and ii) MD-based predictions. D ) Relative to native nMPO (WT), Endo H-treated MPO (P1) showed i) higher thermal stability as determined by CD 208 nm (arrows indicate initial melting temperatures) and ii) greater global polypeptide accessibility based on MD data ( Supplementary Figure S8-S9 ). Key: a–e and i–ii indicate positions of the MPO glycosylation sites and key catalytic residues, respectively. For panel Bii, Ci, and Di: ^Data from Endo H only controls were subtracted from Endo H-treated nMPO data to enable comparison to untreated nMPO. For all panels: Data plotted as mean ± SD, ns, not significant ( p ≥ 0.05), * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001, ***** p < 0.00005.

Article Snippet: Intact nMPO was incubated with or without Streptomyces plicatus endoglycosidase H (Endo H, Promega) under native conditions, 37°C, 16 h. All samples including controls containing only Endo H were used immediately for activity and inhibition profiling and structural characterisation.

Techniques: Activity Assay, Produced, Liquid Chromatography with Mass Spectroscopy

A ) Schematics of the glycoform-dependent ceruloplasmin-based inhibition of Endo H-treated and untreated nMPO. Common glycans decorating Asn323, Asn355, and Asn391 in proximity to the MPO-ceruloplasmin interface and the HOCl-producing active site (yellow star) are portrayed. B ) Glycopeptide data (selected EICs) demonstrating complete conversion of Asn355-M6 and Asn391-M6 to GlcNAcβAsn upon Endo H-treatment ( Supplementary Figure S7 ). The Endo H-insensitive Asn323-M2F was included as a control. C ) The chlorination (i) and relative oxidation (ii-iii) levels of native nMPO (left graphs) and Endo H-treated nMPO (right) incubated with (grey bars) and without (black) serum ceruloplasmin (Cp) were determined in technical triplicates using activity assay 1–3, respectively ( Supplementary Table S5D-F ). ^Data from Endo H and Cp only controls were subtracted from Endo H-and Cp-treated nMPO data to enable comparison to untreated nMPO. D ) MD data of Asn323-M2F (green), Asn355-M6 (magenta) and Asn391-M6 (red) modelled on a crystal structure of the ceruloplasmin-MPO complex (PDBID, 4EJX) demonstrated that Asn355-M6 and not Asn355-GlcNAc clashes with ceruloplasmin (see zoom). Data plotted as mean ± SD, ns, not significant ( p ≥ 0.05), * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.

Journal: bioRxiv

Article Title: Hyper-Truncated Glycans Augment the Activity of Neutrophil Granule Myeloperoxidase

doi: 10.1101/2020.07.24.219956

Figure Lengend Snippet: A ) Schematics of the glycoform-dependent ceruloplasmin-based inhibition of Endo H-treated and untreated nMPO. Common glycans decorating Asn323, Asn355, and Asn391 in proximity to the MPO-ceruloplasmin interface and the HOCl-producing active site (yellow star) are portrayed. B ) Glycopeptide data (selected EICs) demonstrating complete conversion of Asn355-M6 and Asn391-M6 to GlcNAcβAsn upon Endo H-treatment ( Supplementary Figure S7 ). The Endo H-insensitive Asn323-M2F was included as a control. C ) The chlorination (i) and relative oxidation (ii-iii) levels of native nMPO (left graphs) and Endo H-treated nMPO (right) incubated with (grey bars) and without (black) serum ceruloplasmin (Cp) were determined in technical triplicates using activity assay 1–3, respectively ( Supplementary Table S5D-F ). ^Data from Endo H and Cp only controls were subtracted from Endo H-and Cp-treated nMPO data to enable comparison to untreated nMPO. D ) MD data of Asn323-M2F (green), Asn355-M6 (magenta) and Asn391-M6 (red) modelled on a crystal structure of the ceruloplasmin-MPO complex (PDBID, 4EJX) demonstrated that Asn355-M6 and not Asn355-GlcNAc clashes with ceruloplasmin (see zoom). Data plotted as mean ± SD, ns, not significant ( p ≥ 0.05), * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.

Article Snippet: Intact nMPO was incubated with or without Streptomyces plicatus endoglycosidase H (Endo H, Promega) under native conditions, 37°C, 16 h. All samples including controls containing only Endo H were used immediately for activity and inhibition profiling and structural characterisation.

Techniques: Inhibition, Incubation, Activity Assay